Open Insider Trading Activity for Entrada Therapeutics, Inc. Chief Financial Officer Wentworth Kory James
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction TRDA | 2026-04-02 | 2026-04-01 | Entrada Therapeutics, Inc. | Wentworth Kory James | Chief Financial Officer | Sell | 1 | 2,500 | $12.95 | $32,375.00 | 2.06% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction TRDA | 2026-03-11 | 2026-03-10 | Entrada Therapeutics, Inc. | Wentworth Kory James | Chief Financial Officer | Sell | 2 | 16,477 | $13.01 | $214,428.76 | 6.08% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction TRDA | 2026-03-06 | 2026-03-04 | Entrada Therapeutics, Inc. | Wentworth Kory James | Chief Financial Officer | Sell | 1 | 7,988 | $12.25 | $97,853.00 | 5.47% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction TRDA | 2025-11-24 | 2025-11-21 | Entrada Therapeutics, Inc. | Wentworth Kory James | Chief Financial Officer | Sell | 1 | 8,910 | $9.98 | $88,921.80 | 7.49% | View Filing |